Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RORC | P51449 | 3/20 | 0.47 |
| ▸ | GPR119 | Q8TDV5 | 4/20 | 0.47 |
| ▸ | STS | P08842 | 2/20 | 0.46 |
| ▸ | NAMPT | P43490 | 1/20 | 0.45 |
| ▸ | USP30 | Q70CQ3 | 2/20 | 0.45 |
| ▸ | TGFBR1 | P36897 | 1/20 | 0.44 |
| ▸ | NR1H2 | P55055 | 3/20 | 0.43 |
| ▸ | NR1H3 | Q13133 | 2/20 | 0.43 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.43 |
| ▸ | PKM | P14618 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17680273 | 0.88 | GPR119 (0.45) | RORCGPR119STSUSP30NR1H2 | |
| SCHEMBL25326710 | 0.81 | GPR119 (0.48) | RORCGPR119STSNAMPTKDM4E | |
| SCHEMBL2412974 | 0.80 | RORC (0.46) | RORCGPR119STSNAMPTUSP30 | |
| SCHEMBL19707185 | 0.79 | GPR119 (0.47) | GPR119STSNAMPTTGFBR1NR1H2 | |
| SCHEMBL26960975 | 0.79 | KDM4E (0.42) | RORCGPR119STSNAMPTUSP30 | |
| SCHEMBL19640875 | 0.78 | HSD11B1 (0.52) | RORCGPR119STSNAMPTUSP30 | |
| SCHEMBL26966945 | 0.78 | GPR119 (0.47) | GPR119STSNAMPTTGFBR1 | |
| SCHEMBL25255059 | 0.77 | RORC (0.50) | RORCGPR119STSNAMPTNR1H2 | |
| SCHEMBL13947675 | 0.77 | GPR119 (0.59) | GPR119STSNAMPTTGFBR1KDM4E | |
| SCHEMBL23113061 | 0.76 | RORC (0.44) | RORCGPR119STSNAMPTUSP30 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230399302-A1 | PROCESS FOR THE PREPARATION OF HETEROARYL-SUBSTITUTED SULFUR(VI) COMPOUNDS | NATIONAL INSTITUTES OF HEALTH | 2023-12-14 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230399302-A1 | PROCESS FOR THE PREPARATION OF HETEROARYL-SUBSTITUTED SULFUR(VI) COMPOUNDS | TST, TYR, STS | RORC 1600/4885GPR119 4716/4885STS 3/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.